UNresectable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy. A Study to Evaluate the Efficacy and Safety of the Combined Use of Avelumab With Radiation Therapy for the Treatment of Unresectable Cutaneous Squamous Cell Carcinoma
Latest Information Update: 04 Jul 2025
At a glance
- Drugs Avelumab (Primary)
- Indications Skin cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms UNSCARRed
Most Recent Events
- 27 Jun 2025 Status changed from active, no longer recruiting to discontinued.
- 13 Jun 2024 Planned End Date changed from 30 Jun 2023 to 8 Dec 2024.
- 13 Jun 2024 Status changed from recruiting to active, no longer recruiting.